Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Antigüedad A[au]:

Search results

Items: 43

1.

Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.

Vilariño-Güell C, Zimprich A, Martinelli-Boneschi F, Herculano B, Wang Z, Matesanz F, Urcelay E, Vandenbroeck K, Leyva L, Gris D, Massaad C, Quandt JA, Traboulsee AL, Encarnacion M, Bernales CQ, Follett J, Yee IM, Criscuoli MG, Deutschländer A, Reinthaler EM, Zrzavy T, Mascia E, Zauli A, Esposito F, Alcina A, Izquierdo G, Espino-Paisán L, Mena J, Antigüedad A, Urbaneja-Romero P, Ortega-Pinazo J, Song W, Sadovnick AD.

PLoS Genet. 2019 Jun 6;15(6):e1008180. doi: 10.1371/journal.pgen.1008180. eCollection 2019 Jun.

2.

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.

Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilariño-Güell C.

G3 (Bethesda). 2016 Jul 7;6(7):2073-9. doi: 10.1534/g3.116.030841.

3.

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.

Sepúlveda M, Armangué T, Sola-Valls N, Arrambide G, Meca-Lallana JE, Oreja-Guevara C, Mendibe M, Alvarez de Arcaya A, Aladro Y, Casanova B, Olascoaga J, Jiménez-Huete A, Fernández-Fournier M, Ramió-Torrentà L, Cobo-Calvo A, Viñals M, de Andrés C, Meca-Lallana V, Cervelló A, Calles C, Rubio MB, Ramo-Tello C, Caminero A, Munteis E, Antigüedad AR, Blanco Y, Villoslada P, Montalban X, Graus F, Saiz A.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 14;3(3):e225. doi: 10.1212/NXI.0000000000000225. eCollection 2016 Jun.

4.

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.

Mahurkar S, Moldovan M, Suppiah V, Sorosina M, Clarelli F, Liberatore G, Malhotra S, Montalban X, Antigüedad A, Krupa M, Jokubaitis VG, McKay FC, Gatt PN, Fabis-Pedrini MJ, Martinelli V, Comi G, Lechner-Scott J, Kermode AG, Slee M, Taylor BV, Vandenbroeck K, Comabella M, Boneschi FM; Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), King C.

Pharmacogenomics J. 2017 Jul;17(4):312-318. doi: 10.1038/tpj.2016.20. Epub 2016 Mar 22.

PMID:
27001119
5.

Genome-wide significant association with seven novel multiple sclerosis risk loci.

Lill CM, Luessi F, Alcina A, Sokolova EA, Ugidos N, de la Hera B, Guillot-Noël L, Malhotra S, Reinthaler E, Schjeide BM, Mescheriakova JY, Mashychev A, Wohlers I, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Astobiza I, Blaschke P, Boyko AN, Buttmann M, Chan A, Dörner T, Epplen JT, Favorova OO, Fedetz M, Fernández O, García-Martínez A, Gerdes LA, Graetz C, Hartung HP, Hoffjan S, Izquierdo G, Korobko DS, Kroner A, Kubisch C, Kümpfel T, Leyva L, Lohse P, Malkova NA, Montalban X, Popova EV, Rieckmann P, Rozhdestvenskii AS, Schmied C, Smagina IV, Tsareva EY, Winkelmann A, Zettl UK, Binder H, Cournu-Rebeix I, Hintzen R, Zimprich A, Comabella M, Fontaine B, Urcelay E, Vandenbroeck K, Filipenko M, Matesanz F, Zipp F, Bertram L.

J Med Genet. 2015 Dec;52(12):848-55. doi: 10.1136/jmedgenet-2015-103442. Epub 2015 Oct 16.

PMID:
26475045
6.

A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.

Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, Lechner-Scott J, Scott R, Lea R, Taylor BV, Stankovich J, Butzkueven H, Gresle M, Laws SM, Petrou S, Hoffjan S, Akkad DA, Graham CA, Hawkins S, Glaser A, Bedri SK, Hillert J, Matute C, Antiguedad A; ANZgene Consortium, Wiley JS.

Hum Mol Genet. 2015 Oct 1;24(19):5644-54. doi: 10.1093/hmg/ddv278. Epub 2015 Jul 17.

PMID:
26188005
7.

A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis.

Matesanz F, Potenciano V, Fedetz M, Ramos-Mozo P, Abad-Grau Mdel M, Karaky M, Barrionuevo C, Izquierdo G, Ruiz-Peña JL, García-Sánchez MI, Lucas M, Fernández Ó, Leyva L, Otaegui D, Muñoz-Culla M, Olascoaga J, Vandenbroeck K, Alloza I, Astobiza I, Antigüedad A, Villar LM, Álvarez-Cermeño JC, Malhotra S, Comabella M, Montalban X, Saiz A, Blanco Y, Arroyo R, Varadé J, Urcelay E, Alcina A.

Hum Mol Genet. 2015 Oct 1;24(19):5619-27. doi: 10.1093/hmg/ddv256. Epub 2015 Jul 7.

PMID:
26152201
8.

[Introduction. Multiple sclerosis].

Antigüedad AR.

Med Clin (Barc). 2014 Dec;143 Suppl 3:1-2. doi: 10.1016/S0025-7753(15)30001-4. Spanish. No abstract available.

PMID:
25732941
9.

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis.

de la Hera B, Varadé J, García-Montojo M, Alcina A, Fedetz M, Alloza I, Astobiza I, Leyva L, Fernández O, Izquierdo G, Antigüedad A, Arroyo R, Álvarez-Lafuente R, Vandenbroeck K, Matesanz F, Urcelay E.

PLoS One. 2014 Mar 3;9(3):e90182. doi: 10.1371/journal.pone.0090182. eCollection 2014.

10.

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.

International Multiple Sclerosis Genetics Consortium, Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A, Ortiz MA, Pérez J, Damotte V, Booth D, Lopez de Lapuente A, Broer L, Schilling M, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Blaschke P, Buttmann M, Chan A, Compston A, Cournu-Rebeix I, Dörner T, Epplen JT, Fernández Ó, Gerdes LA, Guillot-Noël L, Hartung HP, Hoffjan S, Izquierdo G, Kemppinen A, Kroner A, Kubisch C, Kümpfel T, Li SC, Lindenberger U, Lohse P, Lubetzki C, Luessi F, Malhotra S, Mescheriakova J, Montalban X, Papeix C, Paredes LF, Rieckmann P, Steinhagen-Thiessen E, Winkelmann A, Zettl UK, Hintzen R, Vandenbroeck K, Stewart G, Fontaine B, Comabella M, Urcelay E, Matesanz F, Sawcer S, Bertram L, Zipp F.

Brain. 2013 Jun;136(Pt 6):1778-82. doi: 10.1093/brain/awt101.

11.

Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.

Swaminathan B, Cuapio A, Alloza I, Matesanz F, Alcina A, García-Barcina M, Fedetz M, Fernández O, Lucas M, Orpez T, Pinto-Medel MJ, Otaegui D, Olascoaga J, Urcelay E, Ortiz MA, Arroyo R, Oksenberg JR, Antigüedad A, Tolosa E, Vandenbroeck K.

PLoS One. 2013 Apr 24;8(4):e62376. doi: 10.1371/journal.pone.0062376. Print 2013.

12.

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.

Lill CM, Schjeide BM, Graetz C, Liu T, Damotte V, Akkad DA, Blaschke P, Gerdes LA, Kroner A, Luessi F, Cournu-Rebeix I, Hoffjan S, Winkelmann A, Touze E, Pico F, Corcia P, Otaegui D, Antigüedad A, Alcina A, Comabella M, Montalban X, Olascoaga J, Matesanz F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Rieckmann P, Hartung HP, Aktas O, Lohse P, Buttmann M, Kümpfel T, Kubisch C, Zettl UK, Epplen JT, Fontaine B, Zipp F, Vandenbroeck K, Bertram L.

J Med Genet. 2013 Mar;50(3):140-3. doi: 10.1136/jmedgenet-2012-101411. Epub 2013 Jan 12. No abstract available.

PMID:
23315543
13.

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.

Alcina A, Fedetz M, Fernández O, Saiz A, Izquierdo G, Lucas M, Leyva L, García-León JA, Abad-Grau Mdel M, Alloza I, Antigüedad A, Garcia-Barcina MJ, Vandenbroeck K, Varadé J, de la Hera B, Arroyo R, Comabella M, Montalban X, Petit-Marty N, Navarro A, Otaegui D, Olascoaga J, Blanco Y, Urcelay E, Matesanz F.

J Med Genet. 2013 Jan;50(1):25-33. doi: 10.1136/jmedgenet-2012-101085. Epub 2012 Nov 17.

14.

[Recommendations for the clinical use of motor evoked potentials in multiple sclerosis].

Fernández V, Valls-Sole J, Relova JL, Raguer N, Miralles F, Dinca L, Taramundi S, Costa-Frossard L, Ferrandiz M, Ramió-Torrentà L, Villoslada P, Saiz A, Calles C, Antigüedad A, Alvarez-Cermeño JC, Prieto JM, Izquierdo G, Montalbán X, Fernández O.

Neurologia. 2013 Sep;28(7):408-16. doi: 10.1016/j.nrl.2012.07.007. Epub 2012 Sep 18. Review. Spanish.

15.

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.

Lill CM, Liu T, Schjeide BM, Roehr JT, Akkad DA, Damotte V, Alcina A, Ortiz MA, Arroyo R, Lopez de Lapuente A, Blaschke P, Winkelmann A, Gerdes LA, Luessi F, Fernadez O, Izquierdo G, Antigüedad A, Hoffjan S, Cournu-Rebeix I, Gromöller S, Faber H, Liebsch M, Meissner E, Chanvillard C, Touze E, Pico F, Corcia P; ANZgene Consortium,{dagger}, Dörner T, Steinhagen-Thiessen E, Baeckman L, Heekeren HR, Li SC, Lindenberger U, Chan A, Hartung HP, Aktas O, Lohse P, Kümpfel T, Kubisch C, Epplen JT, Zettl UK, Fontaine B, Vandenbroeck K, Matesanz F, Urcelay E, Bertram L, Zipp F.

J Med Genet. 2012 Sep;49(9):558-62. doi: 10.1136/jmedgenet-2012-101175. Erratum in: J Med Genet. 2012 Oct;49(10):668.

PMID:
22972946
16.

Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis.

Lopez de Lapuente A, Alloza I, Goertsches R, Zettl UK, Urcelay E, Arroyo R, Comabella M, Montalban X, Antigüedad A, Vandenbroeck K.

J Neuroimmunol. 2012 Apr;245(1-2):98-101. doi: 10.1016/j.jneuroim.2012.02.005. Epub 2012 Mar 2.

PMID:
22386267
17.

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes.

Varadé J, Comabella M, Ortiz MA, Arroyo R, Fernández O, Pinto-Medel MJ, Fedetz M, Izquierdo G, Lucas M, Gómez CL, Rabasa AC, Alcina A, Matesanz F, Alloza I, Antigüedad A, García-Barcina M, Otaegui D, Olascoaga J, Saiz A, Blanco Y, Montalbán X, Vandenbroeck K, Urcelay E.

Mult Scler. 2012 Jul;18(7):959-65. doi: 10.1177/1352458511432741. Epub 2011 Dec 22.

PMID:
22194214
18.

ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.

Alloza I, Otaegui D, de Lapuente AL, Antigüedad A, Varadé J, Núñez C, Arroyo R, Urcelay E, Fernandez O, Leyva L, Fedetz M, Izquierdo G, Lucas M, Oliver-Martos B, Alcina A, Saiz A, Blanco Y, Comabella M, Montalban X, Olascoaga J, Matesanz F, Vandenbroeck K.

Genes Immun. 2012 Apr;13(3):253-7. doi: 10.1038/gene.2011.81. Epub 2011 Dec 1.

PMID:
22130326
19.

A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.

Vandenbroeck K, Alvarez J, Swaminathan B, Alloza I, Matesanz F, Urcelay E, Comabella M, Alcina A, Fedetz M, Ortiz MA, Izquierdo G, Fernandez O, Rodriguez-Ezpeleta N, Matute C, Caillier S, Arroyo R, Montalban X, Oksenberg JR, Antigüedad A, Aransay A.

Genes Immun. 2012 Jan;13(1):21-8. doi: 10.1038/gene.2011.44. Epub 2011 Jun 30.

PMID:
21716315
20.

Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.

Cavanillas ML, Fernández O, Comabella M, Alcina A, Fedetz M, Izquierdo G, Lucas M, Cénit MC, Arroyo R, Vandenbroeck K, Alloza I, García-Barcina M, Antigüedad A, Leyva L, Gómez CL, Olascoaga J, Otaegui D, Blanco Y, Saiz A, Montalbán X, Matesanz F, Urcelay E.

Genes Immun. 2011 Mar;12(2):110-5. doi: 10.1038/gene.2010.52. Epub 2010 Oct 14.

PMID:
20944657
21.

Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.

Vandenbroeck K, Alloza I, Swaminathan B, Antigüedad A, Otaegui D, Olascoaga J, Barcina MG, de las Heras V, Bartolomé M, Fernández-Arquero M, Arroyo R, Alvarez-Lafuente R, Cénit MC, Urcelay E.

Genes Immun. 2011 Jan;12(1):40-5. doi: 10.1038/gene.2010.46. Epub 2010 Sep 23.

PMID:
20861862
22.

The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis.

Alcina A, Vandenbroeck K, Otaegui D, Saiz A, Gonzalez JR, Fernandez O, Cavanillas ML, Cénit MC, Arroyo R, Alloza I, García-Barcina M, Antigüedad A, Leyva L, Izquierdo G, Lucas M, Fedetz M, Pinto-Medel MJ, Olascoaga J, Blanco Y, Comabella M, Montalban X, Urcelay E, Matesanz F.

Genes Immun. 2010 Jul;11(5):439-45. doi: 10.1038/gene.2010.30. Epub 2010 May 27.

PMID:
20508602
23.

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.

Swaminathan B, Matesanz F, Cavanillas ML, Alloza I, Otaegui D, Olascoaga J, Cénit MC, de las Heras V, Barcina MG, Arroyo R, Alcina A, Fernandez O, Antigüedad A, Urcelay E, Vandenbroeck K.

J Neuroimmunol. 2010 Jun;223(1-2):100-3. doi: 10.1016/j.jneuroim.2010.03.020. Epub 2010 Apr 28.

PMID:
20430450
24.

ITGA4 polymorphisms and susceptibility to multiple sclerosis.

O'Doherty C, Roos IM, Antiguedad A, Aransay AM, Hillert J, Vandenbroeck K.

J Neuroimmunol. 2007 Sep;189(1-2):151-7. Epub 2007 Aug 8.

PMID:
17689671
25.

Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS).

Benito-León J, Martínez-Martín P, Frades B, Martínez-Ginés ML, de Andrés C, Meca-Lallana JE, Antigüedad AR, Huete-Antón B, Rodríguez-García E, Ruiz-Martínez J.

Mult Scler. 2007 Jun;13(5):645-51. Epub 2007 Feb 16.

PMID:
17548445
26.

Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations.

Suppiah V, Goris A, Alloza I, Heggarty S, Dubois B, Carton H, Antigüedad A, Mendibe M, McDonnell G, Droogan A, Hawkins S, Graham C, Vandenbroeck K.

Int J Immunogenet. 2005 Dec;32(6):383-8.

PMID:
16313303
27.

[Natural interferon-beta in the treatment of relapsing-remitting multiple sclerosis: a multicenter, randomized, MRI-based, phase II clinical trial].

Fernández O, Antigüedad A, Arbizu T, Burgués S, Capdevila A, de Castro P, Correa de Sá JC, García-Merino JA, Izquierdo G, Magalhaes A, Montalbán X, Zarranz JJ.

Rev Neurol. 1999 Dec 16-31;29(12):1093-9. Spanish.

PMID:
10652728
28.

[Antinuclear antibodies in multiple sclerosis].

Antigüedad A, Ruiz J, Mendibe MM, Zarranz JJ.

Neurologia. 1997 Jun-Jul;12(6):245-8. Spanish.

PMID:
9303591
29.

[The practice of neurology by regional specialists in Vizcaya (Spain)].

Antigüedad A, Bárcena J, Pérez Bas M, Aldape J, Hurtado P, Zarranz JJ.

Neurologia. 1995 Oct;10(8):324-9. Spanish.

PMID:
8554782
30.

[Psychotic crisis symptomatic of an outbreak of multiple sclerosis].

Zarranz JJ, Antigüedad AR, Bárcena J.

Neurologia. 1995 May;10(5):205-8. Spanish.

PMID:
7619539
31.

[Generalized idiopathic epilepsy with refractory absence seizures in the adult].

Zarranz JJ, Barcena J, Antigüedad AR.

Neurologia. 1995 Mar;10(3):127-32. Spanish.

PMID:
7756010
32.

[Secondary epilepsy in patients with multiple sclerosis].

Antiguedad A, Sanchez JL, Zaranz JJ.

Neurologia. 1994 Aug-Sep;9(7):311-2. Spanish. No abstract available.

PMID:
7946432
33.

[Epilepsy mal secondary to multiple sclerosis].

Antigüedad A, Sánchez JL, Zarranz JJ.

Neurologia. 1994 Aug-Sep;9(7):311-2. Spanish. No abstract available.

PMID:
7946431
34.

[Eales' disease involving central nervous system white matter].

Antigüedad A, Zarranz JJ.

Neurologia. 1994 Aug-Sep;9(7):307-10. Spanish.

PMID:
7946429
35.

[Multifocal encephalopathy as the principle manifestation of an occult cancer].

Antigüedad AR, Larracoechea J, Calabozo M, Bilbao F, Forcadas MI.

Rev Clin Esp. 1990 Nov;187(8):408-11. Spanish.

PMID:
2091135
36.

[Idiopathic cerebral gas embolism].

Uterga JM, Larracoechea J, Fernández-Rodríguez M, Antigüedad A, Forcadas I, Zarranz JJ.

Neurologia. 1990 Oct;5(8):288-91. Spanish.

PMID:
2099821
37.

[Pure sensory hemisyndromes caused by infarctions in the pons].

Antigüedad AR, Zarranz JJ, Lachen MC, Fernández M, Madoz P.

Neurologia. 1990 May;5(5):164-6. Spanish.

PMID:
2400608
38.

[Chordoma of the 3d ventricle without extradural implantation].

Antigüedad AR, Gómez M, Zarranz JJ.

Neurologia. 1989 Nov;4(9):340-1. Spanish. No abstract available.

PMID:
2638599
39.

[Bilateral progressive optic neuritis of unknown origin].

Antigüedad AR, Forcadas M, Zarranz JJ.

Neurologia. 1989 Mar;4(2):71-2. Spanish. No abstract available.

PMID:
2629901
40.

[Study of inter-observer reliability in the use of qualitative scales assessing Parkinson disease (II)].

Martínez-Martín P, Carrasco de la Peña JL, Ramo C, Antigüedad AR, Bermejo F.

Arch Neurobiol (Madr). 1988 Sep-Oct;51(5):287-91. Spanish. No abstract available.

PMID:
3219024
41.

[Blood glucose as a prognostic factor in cerebral infarction].

Peinado E, Ozaita G, Antiguedad A, Calandre L, Bermejo F.

Neurologia. 1988 Mar-Apr;3(2):50-3. Review. Spanish. No abstract available.

PMID:
3078756
42.

[Inter-observer reproducibility of qualitative scales in Parkinson disease (I)].

Martínez-Martín P, Carrasco de la Peña JL, Ramo C, Antigüedad AR, Bermejo F.

Arch Neurobiol (Madr). 1987 Sep-Oct;50(5):309-14. Spanish. No abstract available.

PMID:
3689090
43.

[Shy-Drager syndrome: description of a clinical case which failed to respond to propranolol, ergotamine and indomethacin].

Rodríguez Vallejo A, Shamdas GJ, Palacios J, Morales MA, Antigüedad A, Hernández J, Portera A.

Arch Neurobiol (Madr). 1986 Jan-Feb;49(1):46-53. Spanish. No abstract available.

PMID:
3707267

Supplemental Content

Loading ...
Support Center